Distinguishing optic disc edema from pseudopapilledema is a common clinical problem that can challenge even the most experienced ophthalmologists (1). Differentiating optic disc edema from an optic disc anomaly is consequential because the recognition of pseudopapilledema obviates unnecessary and costly neurologic testing. In papilledema, an accurate diagnosis will avoid delays in treatment of potentially serious neurologic disorders.
Spectral-domain optical coherence tomography (SD-OCT), principally used in the management of maculopathies and atrophic optic neuropathies, was not specifically designed to evaluate optic disc edema, particularly when swelling is severe. Nonetheless, recent advances in SD-OCT imaging of the optic nerve head (ONH) have proven to be a cost effective, noninvasive, outpatient procedure that helps diagnose and manage optic disc edema and pseudopapilledema (1–4).
This review will focus on a toolbox of SD-OCT scanning modes that complement the retinal nerve fiber layer (RNFL) and ganglion cell–inner plexiform layer (GC-IPL) thickness in the diagnosis and management of an elevated nerve head. Our goal is to provide some practical guidelines with illustrations and cases for the performance and interpretation of the SD-OCT of the ONH.
QUANTITATIVE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY ANALYSIS
Papilledema is a form of optic disc edema caused by an elevated intracranial pressure that extends into the perioptic subarachnoid space. Pressure, at the scleral flange and retrolaminar tissue of the optic nerve, has 2 principal effects as follows: i. axoplasmic stasis that distends prelaminar and peripapillary axons, thickens the peripapillary RNFL, and volumetrically expands the ONH and ii. anterior deformation of the lamina cribrosa and peripapillary tissues (toward the vitreous) (5). These effects are not exclusively pressure induced because optic disc edema in general may also be caused by ischemic, inflammatory, and neoplastic disorders of the optic nerve. SD-OCT can image and quantify each of the following structural effects: peripapillary shape deformations and increases in both the RNFL thickness and ONH volume (1–4).
Retinal Nerve Fiber Layer in Optic Disc Edema
The defining characteristic of papilledema is distension of the papillary and peripapillary nerve fibers. With increasing disc edema, the normally transparent RNFL thickens, opacifies, and blurs the disc margin. As swelling increases, blood vessels become obscured, first at the margin and then on the surface of the optic disc. The Frisén grade is an ordinal scale that defines 6 stages (Grades 0–5) of swelling. SD-OCT measures the overall thickness of the RNFL with a resolution of 3–5 μm and a range of about 50–600 μm. The mean RNFL thickness correlates with the Frisén Grade and provides a continuous metric that reduces interobserver disagreement (6–11).
The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) found that 90% of the eyes with papilledema displayed an abnormal mean RNFL thickness (≥95% of normal controls) (12) consistent with a number of previously published reports using SD-OCT (6,8,10,13). Thickening of the RNFL is not specific to papilledema and may occur with any form of optic disc edema (14–17).
Registration of sequential circular or volume scans makes it possible to monitor the mean and regional RNFL thickness over the course of time (8,11,18). It is particularly effective at detecting small changes that may not be evident by ophthalmoscopy or disc photographs. The IIHTT SD-OCT substudy showed that there was a greater reduction in the mean RNFL thickness among the acetazolamide diet group than the placebo diet group at 6 months (11). This decrease in the mean RNFL thickness can take place within days, if not hours, after a spinal tap or shunt (19,20) Similar improvements were noted in the total retinal thickness (TRT) and ONH volume in eyes successfully treated in the IIHTT (11).
The central question in monitoring the mean RNFL thickness in optic disc edema over the course of time is determining what constitutes a clinically significant change. Much of the uncertainty stems from measurement variability between and within individuals and applying population metrics to an individual patient. This variability is increased in patients with papilledema, especially when swelling is severe (21–23). Although a decreasing mean RNFL thickness in a patient with papilledema is oftentimes a sign of improvement, it may also be an indicator of progressive axonal loss (24–26). This is a distinction that can only be made by simultaneously monitoring visual fields and thickness of the GC-IPL, providing that layer segmentation is accurate.
Some have suggested that small changes in the mean RNFL thickness are inconsequential and that monitoring the fundus and visual field are the principal factors that determine major therapeutic interventions (7). Without deprioritizing either, we suggest that when the mean RNFL thickness drops below 200 μm and the perimetric mean deviation is >−10.00 dB small changes in the mean RNFL thickness in the order of ±10–20 μm may also help provide early warnings of treatment failure. Such changes also help identify therapeutic noncompliance, provide guidance in adjusting medication dosages, and setting appropriate follow-up intervals. Conversely, the stability of the mean RNFL thickness, absent visual field changes, in patients with treated papilledema who for example develop unrelated migraines can be a reassuring indicator.
There are a number of caveats in the interpretation of the RNFL thickness many of which have been reviewed by Chen and Kardon, summarized in Table 1. The most important, with respect to papilledema, is that the segmentation algorithm may fail when papilledema is moderate to severe (mean RNFL > 200 μm) (1,6,12,29–31). Most devices display the segmentation line that defines the RNFL on the circular tomogram that should be checked for accuracy. There is some evidence to suggest that TRT and 3D segmentation algorithms may be less prone to segmentation failures than the mean RNFL thickness in severe papilledema. For the moment, both are limited to investigational studies (6,31–33).
TABLE 1. -
Limitations of the mean RNFL thickness
|No normative values for children younger than 18 years
|No normative adjustments for high myopes
|Adults with “normal” (5%–95% of controls) mean RNFL thickness may still have optic disc edema
Early or mild cases of papilledema (12).
Anatomical variants with thin baseline RNFL thickness (7)
Focal swelling (e.g., in NA-AION)
|Thickening of the RNFL (>95% of controls) without optic disc edema (pseudopapilledema)
Optic disc drusen especially in children (13,27,28)
Other disorders of the optic nerve head and retina: gliosis, myelinated nerve fibers, retinal edema, hyperopia, and epiretinal membranes (29)
|Segmentation failures especially in severe papilledema (1,11,12,29–31)
Low-signal strength ≤6
High myopia and high hyperopia
Decentration of the circular tomogram
Topographic variability of the RNFL bundles and thickness
NA-AION, nonarteritic anterior ischemic optic neuropathy; RNFL, retinal nerve fiber layer.
Notwithstanding these limitations, the RNFL thickness is an effective tool at quantifying the magnitude of disc edema and monitoring changes over the course of time. However, the clinician must be cognizant of its strengths, limitations, and clinical context.
Ganglion Cell–Inner Plexiform Layer in Optic Disc Edema
Thinning of the macular GC-IPL is a sign of neuronal loss that occurs in the atrophic stages of an optic neuropathy, such as glaucoma, optic neuritis, compressive optic neuropathy, and ischemic optic neuropathy. A decrease in the mean RNFL in optic disc edema due to axonal loss will cause thinning of the GC-IPL; whereas a decrease in the mean RNFL due restoration of axoplasmic flow should in theory at least spare the GC-IPL layer (1).
The problem is that commercial algorithms that use 2D imaging to measure the GC-IPL thickness may fail when there is significant ONH swelling. Artifactual thinning occurred in 20% of IIHTT study eyes (12,34). Scans with low-signal strength, outer retinal disorders, epiretinal membranes, and high myopia may also be associated with these segmentation artifacts (29,35,36). Segmentation failures can be reduced using custom 3D segmentation algorithms (12,31,37); however, these are not available in commercial devices. For now the use of GC-IPL in papilledema should be limited to patients with mild (≤Grade II) or chronic forms of papilledema but still need to be validated with a 10-2 visual field (38).
Optic Nerve Head Volume
The SD-OCT measurement of ONH volume is another method of quantifying papilledema. This metric determines the volume of tissue between the internal limiting membrane and Bruch's membrane layer (BML) using a rectangular cube (6 × 6 mm) or a variety of concentric circular grids. ONH volume correlates with the mean RNFL thickness, TRT, and Frisén grade. It is increased in papilledema and other forms of optic disc edema and decreases with successful treatment as shown in the IIHTT (11,12,18,34). Although volume is a standard metric for the evaluation of the macula, its application to the ONH has been limited. It remains to be seen if ONH volume has any advantage over the RNFL thickness in the evaluation of optic disc edema. It has the potential to obviate the segmentation failures of the RNFL in severe papilledema (6,11,12,34).
QUALITATIVE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY ANALYSIS
The qualitative assessment of the SD-OCT includes the cross-sectional transverse axial, radial scans, en face imaging, and circular tomogram. These scanning modes assess a variety of features that are not captured by the metrics of the SD-OCT of the ONH. They include, for example, shape deformations, pseudopapilledema, retinal folds (RF), choroidal folds (CF), retinal edema, inflammation, and hemorrhages among others.
Transverse Axial: Shape and Displacement
Peripapillary shape refers to the configuration of the peripapillary BML on a 9-mm or 30° transverse axial SD-OCT. In selected cases, shape deformations may help evaluate and manage disorders that elevate the ONH.
The mechanical forces that anteriorly deform the posterior pole of the globe (toward the vitreous) include: the intraocular pressure, cerebrospinal fluid (CSF) pressure (sometimes also expressed as the translaminar pressure difference or gradient), retrolaminar tissue pressure, and the orbital tissue pressure. An imbalance between these forces may reshape the globe. The effect is modulated by the structural geometry of the ONH and compliance of the load-bearing structures (sclera, lamina, and dura) (39–42). An increase in the CSF or orbital tissue pressure, a decrease in intraocular pressure, stiffening of the optic nerve, or the optic nerve sheath may cause anterior shape deformations. These deformations can help distinguish optic disc edema from pseudopapilledema.
Experimentally, a change in the translaminar pressure difference causes an anterior or posterior displacement of the optic disc depending on the direction of the gradient (43,44). Clinically, elevation of the CSF pressure flattens the globe; a deformation that can be imaged on MRI (45) (Fig. 1A) or B-scan ultrasonography (46,47). The transverse axial SD-OCT of the ONH and peripapillary tissues can also image flattening of the globe providing a high-resolution, cost effective, alternative to the MRI and ultrasound (Fig. 1B, C) (19,48,49).
Several morphometric approaches have been used to gauge peripapillary deformations and displacements using SD-OCT in patients with intracranial hypertension and papilledema. They include angular deflections of the BML (48,50,51), displacements of BM opening (19) or anterior laminar surface depth (52–55), and geometric morphometric shape analysis (19,49,56,57). Each has limitations. For example, it is not always possible to identify a undisplaced peripheral baseline of BML to measure angular deflections in severe cases of optic disc edema. Because of limited penetrance of near-infrared light of the SD-OCT, the anterior laminar surface is not always visible even with adaptively enhanced swept-source OCT (53). Geometric morphometrics is robust and sensitive but impractical as an office-based clinical tool (49).
Nonetheless, these studies have shown that shape or displacement of BML can be used as an indirect approximation of intracranial pressure especially for monitoring changes over the course of time. Patients with papilledema have a peripapillary shape and anterior laminar surface that is anteriorly deformed or displaced compared with normals, pseudopapilledema, and nonarteritic anterior ischemic optic neuropathy (NA-AION). Moreover, interventions that lower the CSF pressure (e.g., after lumbar puncture, CSF shunts, acetazolamide treatment, and optic nerve sheath fenestrations) cause a relative posterior shape deformation or displacement (19,48–57). Although these anterior deformations are most frequently seen in patients with intracranial hypertension and papilledema, they may also occur, less commonly, in optic nerve sheath meningiomas (16), NA-AION (58), and optic neuritis (48).
In the clinical setting, peripapillary shape is assessed qualitatively with the transverse axial SD-OCT. We have identified several common shape patterns (Fig. 2). The most frequent is a continuum between a flat (F)-shape and V-shape (Fig. 2, V-Flat column) that occurs in normal healthy subjects, pseudopapilledema (with or without optic disc drusen [ODD]), NA-AION, and papillitis. By contrast, anterior deformations and displacements give rise to several distinctive patterns that we describe as a 1) W-shape, 2) S-shape or 3) D-shape or Dome shape (Fig. 2, columns W, S, and D). These occur most frequently in patients with intracranial hypertension, papilledema, and optic nerve sheath meningiomas and rarely in patients with ocular hypotension, optic neuritis, and NA-AION. The absence of anterior shape deformation or displacement in a patient with optic disc edema does not necessarily exclude intracranial hypertension or optic nerve sheath meningiomas (16). Approximately one-third of patients with papilledema may have a “normal” V-F shape. Without a baseline for comparison, it is not possible to determine whether a V-F shape in papilledema is in fact mildly displaced anteriorly relative to its shape when the pressure is normal (Fig. 6).
In selected cases, qualitative peripapillary shape assessments may help as follows: i. distinguish pseudopapilledema from papilledema (Fig. 12); ii. identify shunt failures, particularly in patients with optic atrophy (Fig. 3); iii. evaluate atypical anterior optic neuropathies (Fig. 4); and iv. corroborate small but clinically significant changes in the mean RNFL thickness in patients with intracranial hypertension (Fig. 3).
Image Acquisition and Interpretation
Transverse axial images are best acquired as a high-resolution, wide angle (9 mm or 30°) image with enhanced depth imaging (EDI). The default transverse axial images from many of the commercial SD-OCT devices are vertically stretched indicated in the accompanying scale bars (Fig. 1B, C). Increasing the vertical scale is a useful feature for assessing intraretinal details and shape (59). Avoid the tilted image caused by an off-axis scanning beam relative to the ONH (Fig. 5) (49). This is a common artifact that distorts the ONH shape and affects the mean RNFL thickness (60). The registration method used to compare shape changes over the course of time or between eyes is shown in Figure 6.
Transverse Axial: Pseudopapilledema
Pseudopapilledema With Optic Disc Drusen
The misidentification of ODD usually occurs in the young when ODD are small, buried, and concealed from view. They simulate low-grade papilledema, chronic papilledema, or resolved papilledema because the optic discs are elevated with indistinct disc margins even when the drusen load (in size and number) is small. Ophthalmoscopic signs such as vessel branching anomalies, the absence of venous engorgement, the lack of disc vessel obscuration, and clearly defined peripapillary nerve fibers all support, but do not definitively confirm, the diagnosis of ODD (61). The superficial refractile bodies of chronic papilledema are distinctive pinpoint, glistening, yellow deposits that have been misdiagnosed as ODD (62). Rarely, complications of ODD such as peripapillary subretinal hemorrhages or vascular occlusions may confound the diagnosis. Most confusing are cases with both papilledema and ODD (Fig. 12, see discussion below) (61).
Ancillary testing can help differentiate pseudopapilledema from papilledema but each has limitations. Small changes in papilledema can be difficult to discern, even with serial disc photographs. Late staining of the ONH in pseudopapilledema can be mistaken for disc leakage in papilledema. Computed axial tomography of head to detect calcified ODD is inconvenient and exposes the patient to radiation. Autofluorescence imaging may miss small buried drusen. Ultrasound, long considered the gold standard, may also fail to detect small buried drusen (13,63).
There is an emerging consensus that the SD-OCT is the most sensitive way of detecting ODD (64–66). The Optic Disc Drusen Studies Consortium (66) has proposed criteria for the SD-OCT diagnosis of ODD that consists of a defined, prelaminar, signal poor lesion sometimes associated with a hyperreflective cap or multiple small hyperreflective aggregates within a signal poor core. These findings are occasionally accompanied by small horizontal hyperreflective bands (Fig. 7). Isolated bands have been observed in about 14% of healthy subjects with normal optic discs suggesting that drusen may be more common than previously known (67). There is some evidence, based on long-term follow-up over a 5-year period, to suggest that these hyperreflective lines may represent ODD precursors (68).
A peripapillary hyperreflective ovoid mass like structure (PHOMS, Fig. 7) is an SD-OCT finding in some patients with ODD (69). Early reports on the OCT in ODD have asserted that these are uncalcified precursors of drusen (13,28,70–76). The consortium has argued against this view suggesting instead that these are distended prelaminar axons bulging into the peripapillary retina. Histopathologically, PHOMSs in ODD are uncalcified. Identical structures, shown histopathologically and by SD-OCT, occur in papilledema (77), pseudopapilledema without drusen (78) (see below), and other forms of optic disc edema. Finally, unlike the permanence of ODD, PHOMS dissipate when optic disc edema resolves and is absent in advanced cases of ODD with optic atrophy (79–81).
Image Acquisition and Interpretation
ODD can be overlooked with a poor quality OCT. The ODD Studies Consortium recommends that the SD-OCT imaging mode include densely sampled (B-scan intervals of <30 μm), high-resolution transverse axial images with EDI that spans the diameter of the ONH. They also recommend 6-line radial scans, RNFL thickness, and macular volume scans for GC-IPL (69).
Pseudopapilledema Without Drusen
The tilted optic disc, in its most typical form, is a congenital anomaly characterized by oblique entry of the optic nerve, superonasal elevation, situs inversus, and a rotated oval or D-shaped disc. These features in combination with inferior chorioretinal thinning and superior temporal visual field loss constitute the tilted disc syndrome (TDS) (82). With some exceptions (83), these optic discs are so dysmorphic that they usually are not confused with papilledema (Fig. 8A).
There is a form of pseudopapilledema without drusen sometimes also referred to as tilted optic disc, myopic disc, or congenital disc anomaly. We propose to distinguish this particular anomaly from TDS by referring to this form as a “myopic, obliquely inserted disc” (MOID). The salient funduscopic and OCT features are described in Figure 8B–F. In our experience, this is the single most common reason that patients are referred to “rule out” papilledema or ODD. These optic discs are sometimes confused with papilledema because they are frequently associated with a PHOMS that elevates the nasal disc and obscures the nasal disc margin with a pale C-shaped halo seen funduscopically. Similar features have been previously described by Pichi et al (78) in children with TDS. What they called a “dome-shaped hyperreflective structure” is identical to a PHOMS described in ODD and optic disc edema. The rare occurrence in a MOID of an asymptomatic spontaneously acquired peripapillary subretinal hemorrhage (Fig. 8C) or the late staining nasally on fluorescein angiography can be particularly confounding (Fig. 8D) (84). It is uncertain, if TDS and MOID represent the opposite ends of a continuum or if these are 2 distinct entities with overlapping features (78,84).
Some have asserted that the PHOMSs in patients with MOIDs are uncalcified ODD (70,73). The evidence against this view was discussed in the preceding section (78,80). Irrespective of nomenclature, a PHOMS seems to be a common nonspecific structural feature on SD-OCT in patients with ODD, optic disc edema, and optic disc anomalies, such as MOID and TDS.
Transverse Axial: Other Features
The transverse axial SD-OCT can aid in distinguishing NA-AION from neuroretinitis (85) (Fig. 9). It can also help distinguish the vision loss of an optic neuropathy from a maculopathy. This would include findings such as epiretinal membranes, maculopathies, choroidal neovascular membranes, and pigment epithelial detachments.
En Face Spectral-Domain Optical Coherence Tomography: Wrinkles, Folds, and Creases in Papilledema
The wrinkles, folds, and creases that occur in papilledema are structural consequences of stress and strain of intracranial pressure on the ONH and the load-bearing structures (sclera and lamina cribrosa). Clinically, the recognition of folds strongly supports the diagnosis of optic disc edema and effectively eliminates pseudopapilledema from consideration. They are particularly helpful in distinguishing low-grade papilledema from pseudopapilledema (86,87).
Folds are common in patients with papilledema and other causes of disc edema (77,86–89). Based on the IIHTT, folds were detected with SD-OCT in at least one eye in 73% of patients. SD-OCT was more sensitive in detecting folds than fundus photographs (43%). There were 4 types of folds as follows: peripapillary wrinkles (PPW, 46%), inner RF (IRF, 47%), outer retinal folds and creases (ORF, 20%), and CF (10%). Each has distinctive characteristics with respect to location, pattern, spatial wavelength (λ), temporal course, and underlying biomechanics (86,87). The SD-OCT and photographic features of each type of fold are shown in Figure 10.
PPW, ORF and creases (high-water marks), and IRF usually resolve over a period of months to a year in papilledema and more rapidly in NA-AION and neuroretinitis. On occasion, PPW can persist for years, long after the optic disc edema resolves and thus may provide a telltale sign of mild, resolving, or chronic papilledema (Fig. 11) (85,86,88,89). Although the amplitude of CF may decrease with time, they are distinctively persistent long after the papilledema resolves. We have followed patients with CF for many years, in one case for 15 years without resolution. Patients with “idiopathic” acquired hyperopia and CF even in the absence of optic disc edema should be evaluated for intracranial hypertension (90). This presentation is sometimes seen in patients with sleep apnea. CF with mild disc edema have also been described in spaceflight-associated neuro-ocular syndrome (91,92).
There is a widely held clinical precept that folds do not occur in ODD and that their presence distinguishes optic disc edema from pseudopapilledema. There have been several reports of ODD with CF, but it is not possible to establish a causal connection based on these 3 cases alone (93–95). A number of studies on the SD-OCT of pseudopapilledema with and without drusen have been reported but none specifically commented on the presence of folds (28,64,65,69,96,97). We recently studied the en face and axial SD-OCTs of 102 patients with ODD for PPW, ORF, IRF, and CF (98). One or more types of folds were present in 11 of the 102 (11%) patients with ODD, all of whom had a coexistent optic disc edema due to papilledema (6/11), NA-AION (4/11), or uveitic disc edema (1/11). There were 2 additional patients (2%) with ODD who had PPW without optic disc edema. These findings indicate that the occurrence of folds in ODD is frequently associated with a complication of ODD, such as NA-AION or an unrelated papilledema (Figs. 11, 12). The cause of PPW in 2 of the patients (without optic disc edema) is unknown (86). We cannot exclude a previous subclinical bout of NA-AION or papilledema in either of these patients.
The coexistence of ODD and papilledema (99,100) has generally been assumed to be coincidental (Fig. 12) (2). However, 2 recent studies found a high frequency in adults and children with both ODD and papilledema at 19% (75) and 48% (76); far greater than the estimated prevalence of ODD at 0.3%–2.4% in healthy subjects. Although both studies used multiple modalities, the OCT criteria used to diagnose ODD may have overestimated its frequency by relying on low-resolution Time-domain OCT (with limited penetrance) or basing the diagnosis on PHOMS alone (75,76). Neither study met the recommended criteria for the SD-OCT diagnosis of ODD, and thus it remains uncertain whether there is an association between papilledema and ODD. Nonetheless, we have seen enough of these cases to remain open to the possibility pending a large case series that use the consortium recommendations (66) for the SD-OCT diagnosis of ODD.
Image Acquisition and Interpretation
Proper screening for folds using en face SD-OCT requires optimal positioning of the segmentation lines. The offset must straddle the surface of the retina, and the slab must be thin enough to capture the peaks and troughs of the folds. Some devices require closely spaced B-scan intervals (≤60 μm apart) to obtain en face images. In addition, transverse axial SD-OCT scans must be oriented perpendicular to the fold to be seen (Fig. 13).
Stress Testing the Optic Nerve Head
Ocular ductions induce small alternating “seesaw” deformations of the ONH and peripapillary retina in normal subjects, NA-AION, and ODD. In adduction, the temporal margin of the BML is displaced posteriorly (away from the vitreous), the nasal side moves anteriorly, and the reverse occurs in abduction (101–103). In adduction, stretching the optic nerve sheath tethers the peripapillary tissues temporal to the ONH (104). The magnitude of these seesaw deformations can be measured as a “tilt angle” (Fig. 14). The magnitude of this angle using 1.4× vertically scaled images in normal subjects, NA-AION, and ODD is small, in the order of 2°–4° (105). Although the pattern of deformation in papilledema is the same, the magnitude of the tilt angle is exaggerated (101) (8°–20°) (105) presumably because the mechanical load of the optic nerve sheath is augmented by gaze-induced shifts of the CSF and hydraulic stiffening of the optic nerve and the sheath. Please see Supplemental Digital Content 1 (see GIF image, https://links.lww.com/WNO/A440), which illustrates the seesaw deformations induced by ocular ductions in normal subjects, NA-AION, ODD, and papilledema (101).
The mechanical forces on the ONH induced by ocular ductions can also affect the pattern and distribution of PPW (105). As force increases, the amplitude and the area of the folds increase, and thus PPW located temporally become more evident when the eye is adducted 30° (Fig. 15B). Sometimes, folds that are absent in primary position are only visible in adduction, particularly with large tilt angles (Fig. 15C). This does not seem to be the case in normal subjects and ODD with mild elevation (105). Examining the eye in adduction increases the sensitivity of detecting folds that may help to differentiate papilledema from pseudopapilledema. Large disparities in shape between primary position and adduction, that is, with large tilt angles (Fig. 14B) can also be a sign of intracranial hypertension and optic nerve sheath meningiomas.
En face examination for folds should be considered in all presumed cases of pseudopapilledema even those with ODD. If absent in primary, the patient should be examined in adduction. Although not as sensitive as SD-OCT, the same maneuver can be used with fundus photographs obtained with the eye in adduction.
Summary of the Spectral-Domain Optical Coherence Tomography Toolbox for Disc Edema
In summary, the SD-OCT supplements but does not replace the ophthalmic examination. It helps distinguish low-grade papilledema from pseudopapilledema and aids in monitoring changes. At its core are the quantitative assessments of the mean RNFL and GC-IPL thickness. SD-OCT images can also be assessed qualitatively. This includes the transverse axial scan of the ONH and peripapillary tissues to evaluate shape deformations, pseudopapilledema with and without drusen, peripapillary and macular edema, inflammatory signs, maculopathies, and folds. En face SD-OCT is a sensitive way of screening for PPW and outer retinal creases, both distinctive signs of optic disc edema. The circular tomogram that accompanies the mean RNFL thickness report identifies segmentation failures and transversely oriented folds in the choroid or retina. Finally, examination of the ONH in adduction may expose folds and deformations that may not be evident in primary position in patients with papilledema and other causes of optic disc edema. The interpretation of the SD-OCT depends on an understanding of its limitations and artifacts in the context of the overall history and clinical findings.
STATEMENT OF AUTHORSHIP
Category 1: a. Conception and design: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon; b. Acquisition of data: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon; c. Analysis and interpretation of data: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon. Category 2: a. Drafting the manuscript: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon; b. Revising it for intellectual content: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon. Category 3: a. Final approval of the completed manuscript: P. A. Sibony, M. J. Kupersmith, and R. H. Kardon.
1. Kardon R. Optical coherence tomography in papilledema: what am I missing? J Neuroophthalmol. 2014;34(suppl l):S10–S17.
2. Costello F, Malmqvist L, Hamann S. The role of optical coherence tomography in differentiating optic disc drusen from optic disc edema. Asia Pac J Ophthalmol. 2018;7:271–279.
3. Chen JJ. Optical coherence tomography and neuro-ophthalmology. J Neuroophthalmol. 2018;38:e5–e8.
4. Chen JJ, Costello F. The role of optical coherence tomography in neuro-ophthalmology. Ann Eye Sci. 2018;3:1–18.
5. Hayreh SS. Pathogenesis of optic disc edema in raised intracranial pressure. Prog Retin Eye Res. 2016;50:108–144.
6. Scott CJ, Kardon RH, Lee AG, Frisén L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010;128:705–711.
7. Chen JJ, Trobe JD. Optical coherence tomography should be used routinely to monitor patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2016;36:453–459.
8. Rebolleda G, Muñoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:5197–5200.
9. Contreras I, Noval S, Rebolleda G, Muñoz-Negrete FJ. Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography. Ophthalmology. 2007;114:2338–2344.
10. Ahuja S, Anand D, Dutta TK, Roopesh Kumar VR, Kar SS. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography—a case control study. Clin Neurol Neurosurg. 2015;136:95–99.
11. OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study. Papilledema outcomes from the optical coherence tomography substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology. 2015;122:1939–1945.e2.
12. OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study. Baseline OCT measurements in the Idiopathic Intracranial Hypertension Treatment Trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci. 2014;55:8180–8188.
13. Chang MY, Velez FG, Demer JL, Bonelli L, Quiros PA, Arnold AC, Sadun AA, Pineles SL. Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema. Ophthalmology. 2017;124:1839–1848.
14. Bellusci C, Savini G, Carbonelli M, Carelli V, Sadun AA, Barboni P. Retinal nerve fiber layer thickness in nonarteritic anterior ischemic optic neuropathy: OCT characterization of the acute and resolving phases. Graefes Arch Clin Exp Ophthalmol. 2008;246:641–647.
15. Savini G, Bellusci C, Carbonelli M, Zanini M, Carelli V, Sadun AA, Barboni P. Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT. Arch Ophthalmol. 2006;124:1111–1117.
16. Sibony P, Strachovsky M, Honkanen R, Kupersmith MJ. Optical coherence tomography shape analysis of the peripapillary retinal pigment epithelium layer in presumed optic nerve sheath meningiomas. J Neuroophthalmol. 2014;34:130–136.
17. Cho H, Pillai P, Nicholson L, Sobrin L. Inflammatory papillitis in uveitis: response to treatment and use of optic nerve optical coherence tomography for monitoring. Ocul Immunol Inflamm. 2016;24:194–206.
18. Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264:1370–1380.
19. Sibony P, Kupersmith MJ, Honkanen R, Rohlf FJ, Torab-Parhiz A. Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. Invest Ophthalmol Vis Sci. 2014;55:8223–8231.
20. Gampa A, Vangipuram G, Shirazi Z, Moss HE. Quantitative association between peripapillary Bruch's membrane shape and intracranial pressure. Invest Ophthalmol Vis Sci. 2017;58:2739–2745.
21. Hood DC, Kardon RH. A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res. 2007;26:688–710.
22. Hood DC, Anderson S, Rouleau J, Wenick AS, Grover LK, Behrens MM, Odel JG, Lee AG, Kardon RH. Retinal nerve fiber structure versus visual field function in patients with ischemic optic neuropathy. A test of a linear model. Ophthalmology. 2008;115:904–910.
23. Hood DC, Anderson SC, Wall M, Kardon RH. Structure versus function in glaucoma: an application of a linear model. Invest Ophthalmol Vis Sci. 2007;48:3662–3668.
24. Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2011;258:277–283.
25. Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol. 2012;259:886–894.
26. Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D'Amico D. Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci. 2013;34(suppl 1):S143–S145.
27. Karam EZ, Hedges TR. Optical coherence tomography of the retinal nerve fiber layer in mild papilloedema and pseudopapilloedema. Br J Ophthalmol. 2005;89:294–298.
28. Kulkarni KM, Pasol J, Rosa PR, Lam BL. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography. Ophthalmology. 2014;121:959–963.
29. Chen JJ, Kardon RH. Avoiding clinical misinterpretation and artifacts of optical coherence tomography analysis of the optic nerve, retinal nerve fiber layer, and ganglion cell layer. J Neuroophthalmol. 2016;36:417–438.
30. Aojula A, Mollan SP, Horsburgh J, Yiangou A, Markey KA, Mitchell JL, Scotton WJ, Keane PA, Sinclair AJ. Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fiber layer thickness in idiopathic intracranial hypertension. BMC Ophthalmol. 2018;17:257.
31. Wang JK, Kardon RH, Kupersmith MJ, Garvin MK. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:4069–4075.
32. Garvin MK, Abramoff MD, Kardon R, Russell SR, Wu X, Sonka M. Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search. IEEE Trans Med Imaging. 2008;27:1495–1505.
33. Garvin MK, Abràmoff MD, Wu X, Russell SR, Burns TL, Sonka M. Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images. IEEE Trans Med Imaging. 2009;28:1436–1447.
34. OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55:8173–8179.
35. Kardon RH. Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol. 2011;31:353–361.
36. Kim KE, Jeoung JW, Park KH, Kim DM, Kim SH. Diagnostic classification of macular ganglion cell and retinal nerve fiber layer analysis: differentiation of false-positives from glaucoma. Ophthalmology. 2015;122:502–510.
37. Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M, Kardon RH. Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2015;56:3850–3859.
38. Raza AS, Cho J, de Moraes CG, Wang M, Zhang X, Kardon RH, Liebmann JM, Ritch R, Hood DC. Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol. 2011;129:1529–1536.
39. Morgan WH, Yu DY, Balaratnasingam C. The role of cerebrospinal fluid pressure in glaucoma pathophysiology: the dark side of the optic disc. J Glaucoma. 2008;17:408–413.
40. Sigal IA, Ethier CR. Biomechanics of the optic nerve head. Exp Eye Res. 2009;88:799–807.
41. Sigal IA, Flanagan JG, Tertinegg I, Ethier CR. Modeling individual-specific human optic nerve head biomechanics. Part I: IOP-induced deformations and influence of geometry. Biomech Model Mechanobiol. 2009;8:85–98.
42. Sigal IA, Flanagan JG, Tertinegg I, Ethier CR. Modeling individual-specific human optic nerve head biomechanics. Part II: influence of material properties. Biomech Model Mechanobiol. 2009;8:99–109.
43. Morgan WH, Chauhan BC, Yu DY, Cringle SJ, Alder VA, House PH. Optic disc movement with variations in intraocular and cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci. 2002;43:3236–3242.
44. Morgan WH, Yu DY, Alder VA, Cringle SJ, Cooper RL, House PH, Constable IJ. The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure. Invest Ophthalmol Vis Sci. 1998;39:1419–1428.
45. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998;105:1686–1693.
46. Jacobson DM. Intracranial hypertension and the syndrome of acquired hyperopia with choroidal folds. J Neuroophthalmol. 1995;15:178–185.
47. Atta HR, Byrne SF. The findings of standardized echography for choroidal folds. Arch Ophthalmol. 1988;106:1234–1241.
48. Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Invest Ophthalmol Vis Sci. 2011;52:6558–6564.
49. Sibony P, Kupersmith MJ, Rohlf FJ. Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2011;52:7987–7995.
50. Anand A, Pass A, Urfy MZ, Tang R, Cajavilca C, Calvillo E, Suarez JI, Venkatasubba Rao CP, Bershad EM. Optical coherence tomography of the optic nerve head detects acute changes in intracranial pressure. J Clin Neurosci. 2016;29:73–76.
51. Thompson AC, Bhatti MT, El-Dairi MA. Bruch's membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. J AAPOS. 2018;22:38–43.e3.
52. Garcia-Montesinos J, Munoz-Negrete FJ, de Juan V, Rebolleda G. Relationship between lamina cribrosa displacement and trans-laminar pressure difference in papilledema. Graefes Arch Clin Exp Ophthalmol. 2017;255:1237–1243.
53. Lee WJ, Kim HJ, Park KH, Kim YW, Girard MJA, Mari JM, Kim SK, Phi JH, Jeoung JW. Change in optic nerve after intracranial pressure reduction in children. Ophthalmology. 2017;124:1713–1715.
54. Villarruel JM, Li XQ, Bach-Holm D, Hamann S. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma. Eur J Ophthalmol. 2017;27:55–61.
55. Perez-Lopez M, Ting DS, Clarke L. Lamina cribrosa displacement after optic nerve sheath fenestration in idiopathic intracranial hypertension: a new tool for monitoring changes in intracranial pressure? Br J Ophthalmol. 2014;98:1603–1604.
56. Wang JK, Kardon RH, Ledolter J, Sibony PA, Kupersmith MJ, Garvin MK. Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the Idiopathic Intracranial Hypertension Treatment Trial. Invest Ophthalmol Vis Sci. 2017;58:2554–2565.
57. Wang JK, Sibony PA, Kardon RH, Kupersmith MJ, Garvin MK. Semi-automated 2D Bruch's membrane shape analysis in papilledema using spectral-domain optical coherence tomography. Conference Proceeding SPIE 9417, Medical Imaging 2015: Biomedical Applications in Molecular, Structural, and Functional Imaging; March 17, 2015; Orlendo, FL.
58. Rebolleda G, García-Montesinos J, De Dompablo E, Oblanca N, Muñoz-Negrete FJ, González-López JJ. Bruch's membrane opening changes and lamina cribrosa displacement in non-arteritic anterior ischemic optic neuropathy. Br J Ophthalmol. 2017;101:143–149.
59. Sigal IA, Schuman JS, Ishikawa H, Kagemann L, Wollstein G. A problem of proportions in OCT-based morphometry and a proposed solution. Invest Ophthalmol Vis Sci. 2016;57:484–485.
60. Hong S, Kim CY, Seong GJ. Adjusted peripapillary retinal nerve fiber layer thickness measurements based on the optic nerve head scan angle. Invest Ophthalmol Vis Sci. 2010;51:4067–4074.
61. Brodsky MC. Pediatric Neuroophthalmology. 3rd edition. New York, NY: Springer, 2016.
62. Okun E. Chronic papilledema simulating hyaline bodies of the optic disc. A case report. Am J Ophthalmol. 1962;53:922–927.
63. Kurz-Levin MM, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999;117:1045–1049.
64. Merchant KY, Su D, Park SC, Qayum S, Banik R, Liebmann JM, Ritch R. Enhanced depth imaging optical coherence tomography of optic nerve head drusen. Ophthalmology. 2013;120:1409–1414.
65. Sato T, Mrejen S, Spaide RF. Multimodal imaging of optic disc drusen. Am J Ophthalmol. 2013;156:275–282.e1.
66. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S. The Optic Disc Drusen Studies Consortium recommendations for diagnosis of optic disc drusen using optical coherence tomography. J Neuroophthalmol. 2018;38:299–307.
67. Ghassibi MP, Chien JL, Abumasmah RK, Liebmann JM, Ritch R, Park SC. Optic nerve head drusen prevalence and associated factors in clinically normal subjects measured using optical coherence tomography. Ophthalmology. 2016;124:320–325.
68. Malmqvist L, Li XQ, Hansen MH, Thomsen AK, Skovgaard AM, Olsen EM, Larsen M, Munch IC, Hamann S. Progression over 5 years of prelaminar hyperreflective lines to optic disc drusen in the Copenhagen Child Cohort 2000 Eye Study. J Neuroophthalmol. Feb 2020 (epub ahead of print).
69. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S. The Optic Disc Drusen Studies Consortium recommendations for diagnosis of optic disc drusen using optical coherence tomography. J Neuroophthalmol. 2017;38:299–307.
70. Lee KM, Woo SJ, Hwang JM. Morphologic characteristics of optic nerve head drusen on spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;155:1139–1147.e1.
71. Lee KM, Woo SJ, Hwang JM. Differentiation of optic nerve head drusen and optic disc edema with spectral-domain optical coherence tomography. Ophthalmology. 2011;118:971–977.
72. Traber GL, Weber KP, Sabah M, Keane PA, Plant GT. Enhanced depth imaging optical coherence tomography of optic nerve head drusen: a comparison of cases with and without visual field loss. Ophthalmology. 2017;124:66–73.
73. Lee KM, Woo SJ, Hwang JM. Differentiation between optic disc drusen and optic disc edema using fundus photography. Acta Ophthalmol. 2017;95:e329–e335.
74. Rebolleda G, Kawasaki A, de Juan V, Oblanca N, Muñoz-Negrete FJ. Optical coherence tomography to differentiate papilledema from pseudopapilledema. Curr Neurol Neurosci Rep. 2017;17:74.
75. Birnbaum FA, Johnson GM, Johnson LN, Jun B, Machan JT. Increased prevalence of optic disc drusen after papilloedema from idiopathic intracranial hypertension: on the possible formation of optic disc drusen. Neuroophthalmology. 2016;40:171–180.
76. Gospe SM III, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in pediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100:505–509.
77. Paton L, Holmes G. The pathology of papilledema: a histological study of sixty eyes. Brain. 1911;33:389–432.
78. Pichi F, Romano S, Villani E, Lembo A, Gilardoni F, Morara M, Ciardella AP, Ohno-Matsui K, Nucci P. Spectral-domain optical coherence tomography findings in pediatric tilted disc syndrome. Graefes Arch Clin Exp Ophthalmol. 2014;252:1661–1667.
79. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S. Peripapillary hyperreflective ovoid mass-like structures: is it optic disc drusen or not?: response. J Neuroophthalmol. 2018;38:568–570.
80. Malmqvist L, Sibony PA, Fraser CL, Wegener M, Heegaard S, Skougaard M, Hamann S. Peripapillary ovoid hyperreflectivity in optic disc edema and pseudopapilledema. Ophthalmology. 2018;125:1662–1664.
81. Lee KM, Woo SJ, Hwang JM. Peripapillary hyperreflective ovoid mass-like structures: is it optic disc drusen or not? J Neuroophthalmol. 2018;38:567–568.
82. Witmer MT, Margo CE, Drucker M. Tilted optic disks. Surv Ophthalmol. 2010;55:403–428.
83. Young SE, Walsh FB, Knox DL. The tilted disk syndrome. Am J Ophthalmol. 1976;82:16–23.
84. Sibony P, Fourman S, Honkanen R, El Baba F. Asymptomatic peripapillary subretinal hemorrhage: a study of 10 cases. J Neuroophthalmol. 2008;28:114–119.
85. Zatreanu L, Sibony PA, Kupersmith MJ. Optical coherence tomography in neuroretinitis: epipapillary infiltrates and retinal folds. J Neuroophthalmol. 2017;37:176–178.
86. Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M; OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study. Retinal and choroidal folds in papilledema. Invest Ophthalmol Vis Sci. 2015;56:5670–5680.
87. Sibony PA, Kupersmith MJ; OCT sub-study committee for the NORDIC idiopathic intracranial hypertension study. “Paton's folds” revisited: peripapillary wrinkles, folds, and creases in papilledema. Ophthalmology. 2016;123:1397–1399.
88. Kupersmith MJ, Sibony PA, Feldon SE, Wang JK, Garvin M, Kardon R. The effect of treatment of idiopathic intracranial hypertension on prevalence of retinal and choroidal folds. Am J Ophthalmol. 2017;176:77–86.
89. Kupersmith MJ, Sibony PA, Dave S. Nonarteritic anterior ischemic optic neuropathy induced retinal folds and deformations. Invest Ophthalmol Vis Sci. 2017;58:4286–4291.
90. Griebel SR, Kosmorsky GS. Choroidal folds associated with increased intracranial pressure. Am J Ophthalmol. 2000;129:513–516.
91. Mader TH, Gibson CR, Pass AF, Kramer LA, Lee AG, Fogarty J, Tarver WJ, Dervay JP, Hamilton DR, Sargsyan A, Phillips JL, Tran D, Lipsky W, Choi J, Stern C, Kuyumjian R, Polk JD. Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration spaceflight. Ophthalmology. 2011;118:2058–2069.
92. Lee AG, Mader TH, Gibson CR, Tarver W. Spaceflight-associated neuro-ocular syndrome. JAMA Ophthalmol. 2017;135:992–994.
93. Dignam K. Choroidal folds in association with optic disc drusen. Clin Eye Vis Care. 1997;9:99–107.
94. Fried MS, Koch A. Excessive hypermetropia: review and case report documented by echography. Ann Ophthalmol. 1982;14:15–19.
95. Boldt HC, Byrne SF, DiBernardo C. Echographic evaluation of optic disc drusen. J Clin Neuroophthalmol. 1991;11:85–91.
96. Sarac O, Tasci YY, Gurdal C, Can I. Differentiation of optic disc edema from optic nerve head drusen with spectral-domain optical coherence tomography. J Neuroophthalmol. 2012;32:207–211.
97. Malmqvist L, Lindberg AW, Dahl VA, Jørgensen TM, Hamann S. Quantitatively measured anatomic location and volume of optic disc drusen: an enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci. 2017;58:2491–2497.
98. Abazari A, Sibony PA. The etiology of retinal and choroidal folds in optic disc drusen. Ophthalmology. 2020;56:5670–5680.
99. Rossiter JD, Lockwood AJ, Evans AR. Coexistence of optic disc drusen and idiopathic intracranial hypertension in a child. Eye (Lond). 2005;19:234–235.
100. Katz B, Van Patten P, Rothrock JF, Katzman R. Optic nerve head drusen and pseudotumor cerebri. Arch Neurol. 1988;45:45–47.
101. Sibony PA. Gaze evoked deformations of the peripapillary retina in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2016;57:4979–4987.
102. Sibony PA, Wei J, Sigal IA. Gaze-evoked deformations in optic nerve head drusen: repetitive shearing as a potential factor in the visual and vascular complications. Ophthalmology. 2018;125:929–937.
103. Chang MY, Shin A, Park J, Nagiel A, Lalane RA, Schwartz SD, Demer JL. Deformation of optic nerve head and peripapillary tissues by horizontal duction. Am J Ophthalmol. 2017;174:85–94.
104. Demer JL. Optic nerve sheath as a novel mechanical load on the globe in ocular duction. Invest Ophthalmol Vis Sci. 2016;57:1826–1838.
105. Sibony PA, Hou W. Adduction-induced deformations evoke peripapillary folds in papilledema. Ophthalmology. 2019;126:912–914.